| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1053325931 |
| P356 | DOI | 10.1038/ONC.2010.290 |
| P3181 | OpenCitations bibliographic resource ID | 4713073 |
| P698 | PubMed publication ID | 20661218 |
| P5875 | ResearchGate publication ID | 45366823 |
| P2093 | author name string | J Yuan | |
| A Krämer | |||
| K Strebhardt | |||
| K Sommer | |||
| F Rödel | |||
| M Sanhaji | |||
| N N Kreis | |||
| P2860 | cites work | The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 | Q24317677 |
| Activation of p53 in cervical carcinoma cells by small molecules. | Q24644964 | ||
| Surfing the p53 network | Q28032484 | ||
| Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells | Q28267868 | ||
| Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo | Q28281137 | ||
| Live or let die: the cell's response to p53 | Q29547663 | ||
| The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 | Q29547773 | ||
| Regulating the p53 pathway: in vitro hypotheses, in vivo veritas | Q29615658 | ||
| Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol | Q30856412 | ||
| Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2 | Q33643799 | ||
| The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. | Q33889383 | ||
| Endoplasmic reticulum stress accelerates p53 degradation by the cooperative actions of Hdm2 and glycogen synthase kinase 3beta | Q34097322 | ||
| Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinases | Q34298718 | ||
| Awakening guardian angels: drugging the p53 pathway | Q35014385 | ||
| INK4a/ARF: a multifunctional tumor suppressor locus | Q36119162 | ||
| The ARF tumour suppressor | Q36442822 | ||
| The complexity of p53 stabilization and activation | Q36443523 | ||
| Living with p53, dying of p53. | Q36919156 | ||
| Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia | Q37518473 | ||
| Phosphorylation studies on rat p53 using the baculovirus expression system. Manipulation of the phosphorylation state with okadaic acid and influence on DNA binding | Q38297617 | ||
| Functional and spatial regulation of mitotic centromere-associated kinesin by cyclin-dependent kinase 1. | Q39718774 | ||
| E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells | Q39874615 | ||
| Elevation of cyclin B1, active cdc2, and HuR in cervical neoplasia with human papillomavirus type 18 infection. | Q40320764 | ||
| Flavopiridol induces p53 via initial inhibition of Mdm2 and p21 and, independently of p53, sensitizes apoptosis-reluctant cells to tumor necrosis factor | Q40554349 | ||
| Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function | Q41036948 | ||
| Activation of p53 by roscovitine-mediated suppression of MDM2 expression | Q43652194 | ||
| Long-term downregulation of Polo-like kinase 1 increases the cyclin-dependent kinase inhibitor p21(WAF1/CIP1). | Q44325791 | ||
| Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. | Q45345467 | ||
| CDK9 phosphorylates p53 on serine residues 33, 315 and 392 | Q82904823 | ||
| P433 | issue | 41 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | human papillomavirus 16 | Q69461345 |
| P304 | page(s) | 5591-603 | |
| P577 | publication date | 2010-10-14 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Restoration of the tumor suppressor p53 by downregulating cyclin B1 in human papillomavirus 16/18-infected cancer cells | |
| P478 | volume | 29 |
| Q91709241 | A squalamine derivative, NV669, as a novel PTP1B inhibitor: in vitro and in vivo effects on pancreatic and hepatic tumor growth |
| Q36839342 | B-cell lymphoma 6 promotes proliferation and survival of trophoblastic cells |
| Q59791930 | CREPT/RPRD1B associates with Aurora B to regulate Cyclin B1 expression for accelerating the G2/M transition in gastric cancer |
| Q34028486 | Chk1-induced CCNB1 overexpression promotes cell proliferation and tumor growth in human colorectal cancer |
| Q51411634 | Deficiency of RITA results in multiple mitotic defects by affecting microtubule dynamics. |
| Q38626547 | EZH2 silencing with RNA interference induces G2/M arrest in human lung cancer cells in vitro |
| Q34998646 | Function of survivin in trophoblastic cells of the placenta |
| Q38856254 | Functional analysis of phosphorylation of the mitotic centromere-associated kinesin by Aurora B kinase in human tumor cells |
| Q45879282 | Functional study of dextran-graft-poly((2-dimethyl amino)ethyl methacrylate) gene delivery vector for tumor therapy |
| Q90577178 | Identification of genes associated with cancer progression and prognosis in lung adenocarcinoma: Analyses based on microarray from Oncomine and The Cancer Genome Atlas databases |
| Q42279298 | In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancer |
| Q33656171 | Induction of p53, p21 and apoptosis by silencing the NF90/NF45 complex in human papilloma virus-transformed cervical carcinoma cells |
| Q35879549 | Induction of p53-independent growth inhibition in lung carcinoma cell A549 by gypenosides |
| Q47193781 | Involvement of the oncogene B-cell lymphoma 6 in the fusion and differentiation process of trophoblastic cells of the placenta |
| Q90056924 | LINC00346 Acts as a Competing Endogenous RNA Regulating Development of Hepatocellular Carcinoma via Modulating CDK1/CCNB1 Axis |
| Q60909052 | MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1 |
| Q37580380 | Mitotic p21Cip1/CDKN1A is regulated by cyclin-dependent kinase 1 phosphorylation. |
| Q40691202 | NF-Y loss triggers p53 stabilization and apoptosis in HPV18-positive cells by affecting E6 transcription. |
| Q39372427 | Pharmaceutically inhibiting polo-like kinase 1 exerts a broad anti-tumour activity in retinoblastoma cell lines |
| Q35235743 | Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo |
| Q41866750 | Polo-like kinase 1 inhibitors, mitotic stress and the tumor suppressor p53. |
| Q37709250 | Prognostic role of cyclin B1 in solid tumors: a meta-analysis |
| Q90705829 | Regulating the CCNB1 gene can affect cell proliferation and apoptosis in pituitary adenomas and activate epithelial-to-mesenchymal transition |
| Q40883768 | Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors |
| Q37716490 | Targeted breast cancer therapy by harnessing the inherent blood group antigen immune system |
| Q41694208 | The activity regulation of the mitotic centromere-associated kinesin by Polo-like kinase 1 |
| Q39045570 | p21Waf1/Cip1 deficiency causes multiple mitotic defects in tumor cells |
Search more.